Cystic Fibrosis Canada / Fibrose kystique Canada Revenue and Competitors
Estimated Revenue & Valuation
- Cystic Fibrosis Canada / Fibrose kystique Canada's estimated annual revenue is currently $15M per year.
- Cystic Fibrosis Canada / Fibrose kystique Canada's estimated revenue per employee is $114,504
Employee Data
- Cystic Fibrosis Canada / Fibrose kystique Canada has 131 Employees.
- Cystic Fibrosis Canada / Fibrose kystique Canada grew their employee count by 7% last year.
Cystic Fibrosis Canada / Fibrose kystique Canada's People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | Chief Development Officer | Reveal Email/Phone |
3 | Chief Marketing and Communications Officer | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | Development Officer, National Stewardship & Communications | Reveal Email/Phone |
6 | Director, Government and Community Relations | Reveal Email/Phone |
7 | Chief Financial Officer | Reveal Email/Phone |
8 | Regional Executive Director, BC/Yukon | Reveal Email/Phone |
9 | Director, Marketing and Communications | Reveal Email/Phone |
10 | Director, Marketing & Communications | Reveal Email/Phone |
Cystic Fibrosis Canada / Fibrose kystique Canada Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $35M | 341 | 2% | N/A | N/A |
#2 | $1.7M | 19 | 6% | N/A | N/A |
#3 | $75M | 1028 | 8% | N/A | N/A |
#4 | $75M | 1260 | 5% | N/A | N/A |
#5 | $3.5M | 34 | 10% | N/A | N/A |
#6 | N/A | 45 | 50% | N/A | N/A |
#7 | $7.5M | 4 | 33% | N/A | N/A |
#8 | $15M | 111 | -21% | N/A | N/A |
#9 | $15M | 367 | 5% | N/A | N/A |
#10 | $3.5M | 140 | 4% | N/A | N/A |
What Is Cystic Fibrosis Canada / Fibrose kystique Canada?
Cystic Fibrosis Canada (Fibrose kystique Canada in French) is a national charitable not-for-profit corporation established in 1960, and is one of the world's top three charitable organizations committed to finding a cure for cystic fibrosis (CF). As an internationally recognized leader in funding innovation and clinical care, we invest more in life-saving CF research and care than any other non-governmental agency in Canada. Since establishment, Cystic Fibrosis Canada has invested more than $244 million in leading research, innovation and care. As a result, Canadians with cystic fibrosis have one of the highest median survival rates in the world. We rely on the generous support of our volunteers, donors, and partners in our shared mission to improve the lives of Canadians living with cystic fibrosis, and ultimately to find a cure for this devastating disease. * Fondé en 1960, Fibrose kystique Canada est un organisme de bienfaisance national sans but lucratif qui compte parmi les trois principaux organismes caritatifs engagés dans la recherche dun traitement curatif contre la fibrose kystique dans le monde. Il est un chef de file de renommée internationale pour la recherche, linnovation et les soins cliniques liés à la fibrose kystique. Fibrose kystique Canada investit plus dargent dans la recherche et les soins essentiels à la vie des personnes fibro-kystiques que tout autre organisme non gouvernemental au Canada. Depuis sa fondation, Fibrose kystique Canada a investi plus de 244 millions de dollars dans la recherche et les soins cliniques de pointe. Les taux de survie des Canadiens fibro-kystiques sont dailleurs parmi les plus élevés au monde. Nous comptons sur la générosité de nos nombreux bénévoles, donateurs et partenaires pour réaliser notre mission commune, qui est daméliorer la vie des Canadiens atteints de fibrose kystique et de trouver un traitement curatif contre cette maladie dévastrice.
keywords:N/AN/A
Total Funding
131
Number of Employees
$15M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cystic Fibrosis Canada / Fibrose kystique Canada News
Le rapport de recherche sur la taille du marché mondial Dispositifs de dégagement des voies respiratoires pour la fibrose kystique 2022...
Santé Canada autorise la commercialisation de TRIKAFTAMD ... de la fibrose kystique (cystic fibrosis transmembrane conductance regulator,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $32.9M | 131 | 2% | N/A |
#2 | $27.5M | 131 | 10% | N/A |
#3 | $32.9M | 131 | -18% | N/A |
#4 | $32.9M | 131 | -2% | N/A |
#5 | $15M | 131 | 7% | N/A |